Thalassiolins A-C: new marine-derived inhibitors of HIV cDNA integrase

Bioorg Med Chem. 2002 Nov;10(11):3619-25. doi: 10.1016/s0968-0896(02)00241-9.

Abstract

Human immunodeficiency virus (HIV) replication requires integration of viral cDNA into the host genome, a process mediated by the viral enzyme integrase. We describe a new series of HIV integrase inhibitors, thalassiolins A-C (1-3), isolated from the Caribbean sea grass Thalassia testudinum. The thalassiolins are distinguished from other flavones previously studied by the substitution of a sulfated beta-D-glucose at the 7-position, a substituent that imparts increased potency against integrase in biochemical assays. The most active of these molecules, thalassiolin A (1), displays in vitro inhibition of the integrase catalyzed strand transfer reaction (IC50=0.4 microM) and an antiviral IC50 of 30 microM. Molecular modeling studies indicate a favorable binding mode is probable at the catalytic core domain of HIV-1 integrase.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Binding Sites
  • Cells, Cultured
  • Chromatography, High Pressure Liquid
  • DNA, Complementary / drug effects*
  • Flavonoids / isolation & purification
  • Flavonoids / pharmacology*
  • HIV Infections / drug therapy
  • HIV Integrase / drug effects*
  • HIV Integrase Inhibitors / pharmacology*
  • HIV-1 / drug effects
  • HIV-1 / enzymology
  • Humans
  • Hydrocharitaceae / chemistry*
  • Indicators and Reagents
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Molecular Conformation
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • DNA, Complementary
  • Flavonoids
  • HIV Integrase Inhibitors
  • Indicators and Reagents
  • Thalassiolin C
  • thalassiolin A
  • thalassiolin B
  • HIV Integrase